In decompensated cirrhosis, patients are symptomatic, due to significant fibrotic changes, and present with one or more of the following: ascites, jaundice, hepatic encephalopathy, or variceal hemorrhage.(2) Of note cirrhosis is one of five conditions encompassed by the broad category metabolic dysfunction-associated steatotic liver disease (MASLD).(3) Background: How GLP-1 RAs Work and Potential Cirrhosis Benefit GLP-1 RAs stimulate prandial insulin secretion, limiting glucagon production, slowing gastric motility and increasing satiety
IU and dosing math for researchers U100 insulin syringes calibrate volume in international units where 100 IU equals 1 mL, so 1 IU equals 0.01 mL
Adamo, C
Sometimes slowing the dose escalation schedule, adjusting meal timing, or exploring alternative GLP-1 formulations can reduce reflux while maintaining weight loss progress
Due to the use of the pan HDACi in the present work, the detailed HDAC isoform has not been definitively identified for the contribution to the neurological manifestations in the TSC
GLP-1 analogs are reshaping diabetes and obesity care, but sex differences in their effects are emerging